학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 117건 | 목록 1~10
Academic Journal
Lin DI; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Huang RSP; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Ladas I; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Keller RB; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Patel NR; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Lakis S; Foundation Medicine GmbH, Pathology Department, Penzberg, Germany.; Decker B; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Janovitz T; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Mata DA; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Ross JS; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Vergilio JA; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Elvin JA; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.; Herbst RS; Department of Medical Oncology, Yale School of Medicine, Yale Cancer Center, New Haven, CT, United States.; Mack PC; Division of Hematology and Oncology, Department of Medicine, Tisch Cancer Institute at Mount Sinai, New York, NY, United States.; Killian JK; Department of Pathology and Diagnostic Medicine, Foundation Medicine, Inc., Cambridge, MA, United States.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Keller RB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kapner KS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dilly J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Biological and biomedical sciences program, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Raghavan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cohen EF; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Tolstorukov M; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Andrews E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; da Silva A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Weill Cornell Medical College, New York, New York.; Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Surana R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Clancy TE; Harvard Medical School, Boston, Massachusetts.; Division of Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Schlechter BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Clark JW; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Rosenthal MH; Department of Radiology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.; Hornick JL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Nardi V; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.; Li YY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Gupta H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Nowak JA; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Tung N; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Dougherty KC; Foundation Medicine, Inc., Cambridge, MA, USA.; Gatof ES; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; DeLeonardis K; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Hogan L; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Tukachinsky H; Foundation Medicine, Inc., Cambridge, MA, USA.; Gornstein E; Foundation Medicine, Inc., Cambridge, MA, USA.; Oxnard GR; Foundation Medicine, Inc., Cambridge, MA, USA.; McGregor K; Foundation Medicine, Inc., Cambridge, MA, USA.; Keller RB; Foundation Medicine, Inc., Cambridge, MA, USA. rkeller@foundationmedicine.com.
Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Academic Journal
Keller RB; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Mazor T; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Sholl L; Center for Advanced Molecular Diagnostics, Brigham & Women's Hospital & Harvard Medical School, Boston, MA.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Sethi N; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Bass A; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Nagaraja AK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Hill E; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Hennessey C; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Cusick M; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Del Vecchio Fitz C; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Zwiesler Z; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Siegel E; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Ovalle A; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Trukhanov P; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Hansel J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Chan JA; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Corsello SM; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Enzinger AC; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Enzinger PC; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Perez KJ; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Wisch JS; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Hassett MJ; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; MacConaill L; Center for Advanced Molecular Diagnostics, Brigham & Women's Hospital & Harvard Medical School, Boston, MA.; Schrag D; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Cerami E; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Nowak JA; Center for Advanced Molecular Diagnostics, Brigham & Women's Hospital & Harvard Medical School, Boston, MA.; Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Klein H; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA. hrklein@ds.dfci.harvard.edu.; Mazor T; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA. tmazor@ds.dfci.harvard.edu.; Siegel E; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.; Trukhanov P; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.; Ovalle A; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.; Vecchio Fitz CD; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.; Zwiesler Z; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.; Kumari P; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.; Van Der Veen B; The Hyve, Utrecht, The Netherlands.; Marriott E; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.; Hansel J; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.; Yu J; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.; Albayrak A; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA.; Barry S; Dana-Farber Cancer Institute, Boston, MA, USA.; Keller RB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; MacConaill LE; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Lindeman N; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Johnson BE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Rollins BJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Do KT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Beardslee B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Shapiro G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Hector-Barry S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Methot J; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA.; Sholl L; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Lindsay J; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.; Hassett MJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cerami E; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Keller RB
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어